CV Sciences, Inc. (CVSI)
- Previous Close
0.0380 - Open
0.0393 - Bid --
- Ask --
- Day's Range
0.0361 - 0.0398 - 52 Week Range
0.0300 - 0.0600 - Volume
80,457 - Avg. Volume
245,325 - Market Cap (intraday)
6.195M - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
1.90 - EPS (TTM)
0.0200 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
www.cvsciences.com42
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CVSI
Performance Overview: CVSI
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CVSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CVSI
Valuation Measures
Market Cap
6.19M
Enterprise Value
5.32M
Trailing P/E
1.90
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.37
Price/Book (mrq)
2.13
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
1.48
Financial Highlights
Profitability and Income Statement
Profit Margin
19.38%
Return on Assets (ttm)
20.58%
Return on Equity (ttm)
291.82%
Revenue (ttm)
16M
Net Income Avi to Common (ttm)
3.1M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.32M
Total Debt/Equity (mrq)
15.23%
Levered Free Cash Flow (ttm)
439.38k
Research Analysis: CVSI
Company Insights: CVSI
CVSI does not have Company Insights